Physitrack PLC ("Physitrack" or the "Company") announces that, pursuant to the share buy-back programme announced on 21 July 2026, the Company has purchased its own ordinary shares on Nasdaq First North Growth Market Stockholm during the week of 14 September 2026 to 18 September 2026, as set out below.
Summary of transactions
| Period | Total shares repurchased during the week | Volume-weighted average price paid (SEK) | Total consideration paid (SEK) | Total shares held by the Company (treasury) following these transactions | Total outstanding shares in the Company | Treasury holding as % of issued share capital |
| 14 September 2026 - 18 September 2026 | 5,649 | SEK 8.8108 | SEK 49,772.44 | 38,682 | 16,260,766 | 0.2379% |
Individual transactions
| Date | Quantity | Average price (SEK) |
| 2026-09-14 | 1,500 | 8.7400 |
| 2026-09-15 | 1,500 | 8.8800 |
| 2026-09-16 | 1,219 | 8.8420 |
| 2026-09-17 | 1,000 | 8.7800 |
| 2026-09-18 | 430 | 8.4598 |
The share buy-back programme is conducted within the safe harbour of Article 5 of the Market Abuse Regulation (EU) No 596/2014 ("MAR") and Commission Delegated Regulation (EU) 2016/1052, for the purpose of meeting the Company's obligations under its employee share plans. The programme is executed by Pareto Securities on a non-discretionary basis on Nasdaq First North Growth Market Stockholm.
Notification details
| 1. Issuer | Physitrack PLC, LEI 213800PC4QYNWHPCP774 |
| 2. Instrument/ISIN | Ordinary shares / GB00BYX22590 |
| 3. Trading venue | Nasdaq First North Growth Market Stockholm (PTRK) |
| 4. Currency | SEK |
| 5. Purpose of buy-back | To meet the Company's obligations under its employee share plans (a permitted purpose under Article 5(2) of MAR) |
| 6. Executing broker | Pareto Securities (non-discretionary mandate) |
This information is disclosed pursuant to Article 5 of MAR and Commission Delegated Regulation (EU) 2016/1052.